Nano-encapsulated ferulic acid in sesame protein isolate alleviates acrylamide-induced liver toxicity and genotoxicity in rats via oxidative stress and DNA damage modulation.

IF 2.7 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Hend A Essa, Elham Ali, Fatma El Zahraa Abd El Hakam, Engy M Akl
{"title":"Nano-encapsulated ferulic acid in sesame protein isolate alleviates acrylamide-induced liver toxicity and genotoxicity in rats via oxidative stress and DNA damage modulation.","authors":"Hend A Essa, Elham Ali, Fatma El Zahraa Abd El Hakam, Engy M Akl","doi":"10.1186/s40360-025-00946-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acrylamide (ACR) induces hepatotoxicity and genotoxicity through oxidative stress and inflammatory processes.</p><p><strong>Aims: </strong>This study explores the potential of ferulic acid encapsulated in sesame protein isolate (SPI) and its nanoform as a non-toxic, effective therapy for ACR-induced oxidative liver injury in rats.</p><p><strong>Methods: </strong>SPI was prepared from defatted sesame flour. SPI exposed to ultrasonic waves to obtain nano SPI, and then ferulic acid was added to form capsules. Fourier transforms infrared spectra, scaning electron microscope, and polarizing optical microscope were used in investigating functional groups and surface morphology of both encapsulations respectively. Rats were divided into four groups, each consisting of six animals: normal control, ACR-treated (20 mg/kg/day), sesame protein encapsulated ferulic acid-treated, and sesame protein nano-encapsulated ferulic acid-treated groups. Both encapsulated forms were administered daily in the diet alongside ACR for two weeks. Liver function indices, oxidative stress biomarkers, DNA fragmentation, comet assay, and histopathological and immunohistochemical examinations were performed.</p><p><strong>Results: </strong>The encapsulation efficiency of the nano-encapsulated form was higher than that of the other forms. Both encapsulated forms significantly improved liver function, elevated levels of GSH, GPx, SOD, and CAT were observed, along with decreased concentrations of MDA, interleukin-6, and tumor necrosis factor-α. The treatments also provided protection against DNA damage and genotoxicity, alleviated histological damage, and reduced liver toxicity and genotoxicity.</p><p><strong>Conclusion: </strong>Both encapsulated forms, especially the nanoform, significantly mitigated liver toxicity. These findings underscore their potential as effective natural therapies for liver damage caused by ACR, and supporting liver health.</p>","PeriodicalId":9023,"journal":{"name":"BMC Pharmacology & Toxicology","volume":"26 1","pages":"120"},"PeriodicalIF":2.7000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12166574/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40360-025-00946-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acrylamide (ACR) induces hepatotoxicity and genotoxicity through oxidative stress and inflammatory processes.

Aims: This study explores the potential of ferulic acid encapsulated in sesame protein isolate (SPI) and its nanoform as a non-toxic, effective therapy for ACR-induced oxidative liver injury in rats.

Methods: SPI was prepared from defatted sesame flour. SPI exposed to ultrasonic waves to obtain nano SPI, and then ferulic acid was added to form capsules. Fourier transforms infrared spectra, scaning electron microscope, and polarizing optical microscope were used in investigating functional groups and surface morphology of both encapsulations respectively. Rats were divided into four groups, each consisting of six animals: normal control, ACR-treated (20 mg/kg/day), sesame protein encapsulated ferulic acid-treated, and sesame protein nano-encapsulated ferulic acid-treated groups. Both encapsulated forms were administered daily in the diet alongside ACR for two weeks. Liver function indices, oxidative stress biomarkers, DNA fragmentation, comet assay, and histopathological and immunohistochemical examinations were performed.

Results: The encapsulation efficiency of the nano-encapsulated form was higher than that of the other forms. Both encapsulated forms significantly improved liver function, elevated levels of GSH, GPx, SOD, and CAT were observed, along with decreased concentrations of MDA, interleukin-6, and tumor necrosis factor-α. The treatments also provided protection against DNA damage and genotoxicity, alleviated histological damage, and reduced liver toxicity and genotoxicity.

Conclusion: Both encapsulated forms, especially the nanoform, significantly mitigated liver toxicity. These findings underscore their potential as effective natural therapies for liver damage caused by ACR, and supporting liver health.

芝麻分离蛋白中的纳米阿魏酸通过氧化应激和DNA损伤调节减轻丙烯酰胺诱导的大鼠肝毒性和遗传毒性。
背景:丙烯酰胺(Acrylamide, ACR)通过氧化应激和炎症过程诱导肝毒性和遗传毒性。目的:本研究探讨了芝麻分离蛋白(SPI)包被阿魏酸及其纳米形态作为一种无毒、有效治疗acr诱导的大鼠氧化性肝损伤的潜力。方法:以脱脂芝麻粉为原料制备SPI。SPI经超声波照射得到纳米SPI,再加入阿魏酸制成胶囊。利用傅里叶变换红外光谱、扫描电镜和偏光显微镜分别研究了两种包封材料的官能团和表面形貌。将大鼠分为4组,每组6只:正常对照组、acr处理组(20 mg/kg/day)、芝麻蛋白包封阿魏酸组和芝麻蛋白纳米包封阿魏酸组。这两种胶囊形式都是每天在饮食中与ACR一起服用两周。进行肝功能指标、氧化应激生物标志物、DNA片段化、彗星分析、组织病理学和免疫组织化学检查。结果:纳米包封形式的包封效率高于其他包封形式。两种包封形式均显著改善肝功能,GSH、GPx、SOD和CAT水平升高,MDA、白细胞介素-6和肿瘤坏死因子-α浓度降低。对DNA损伤和遗传毒性具有保护作用,减轻了组织损伤,降低了肝毒性和遗传毒性。结论:两种包封形式,尤其是纳米形式,均能显著减轻肝毒性。这些发现强调了它们作为ACR引起的肝损伤的有效自然疗法的潜力,并支持肝脏健康。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology PHARMACOLOGY & PHARMACYTOXICOLOGY&nb-TOXICOLOGY
CiteScore
4.80
自引率
0.00%
发文量
87
审稿时长
12 weeks
期刊介绍: BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信